Location permission needed for a better experience.
How can we help you?
CV
Memberships
Publications
Education
  • 2009 - 2014 Marmara Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı / Doçent
  • 2014 Marmara Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı / Profesör
  • 2011 Tıpta Uzmanlık Kurulu Çocuk Ürolojisi
  • 2007 - 2009 Marmara Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı / Yardımcı Doçent
  • 2002 Hacettepe Üniversitesi Tıp Fakültesi Üroloji
  • 1997 Marmara Üniversitesi Tıp Fakültesi
Experience
  • 2021 Acıbadem Sağlık Grubu
  • 2006 - 2017 Marmara Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı / Üroloji Uzmanı
  • 2005 - 2006 Gülhane Askeri Tıp Akademisi, Çocuk Ürolojisi Bilim Dalı / Üroloji Uzmanı
  • 2004 - 2005 Indiana University School of Medicine /Department of Pediatric Urology / Riley Children Hospital
  • 2002 - 2004 Hacettepe Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı / Çocuk Ürolojisi
  • 2002 Astra Zeneca Scholarship Program / Vanderbilt University Medical Centre Nashville/Tennessee
  • 2001 European Urological Scholarship Program Erasmus University
Memberships
  • Türk Çocuk Ürolojisi Derneği
  • Avrupa Üroloji Derneği (EAU)
  • Avrupa Çocuk Ürolojisi Derneği (ESPU)
  • Ankara Ürologlar Derneği
  • Ürolojik Cerrahi Derneği
  • Türk Tabipler Birliği
Publications
  • The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity du Neurourol Urodyn. 2017 Jan 16. Top T, Sekerci CA, Isbllen-Basok B, Tanidir Y, Tinay I, Isman FK, Akbal C, Simsek E, Tarcan T.
  • Is 40 cm H(2) O detrusor leak point pressure cut-off reliable for upper urinary tract protection in children with myelodysplasia? Neurourol Urodyn. 2016 Apr 15. doi: 10.1002/nau.23017. [Epub ahead of print] PubMed PMID: 27080436. Tarcan T, Sekerci CA, Akbal C, Tinay I, Tanldir Y, Sahan A, Sahin B, Top T, Simsek F.
  • Effects of platelet-rich plasma against experimental ischemia/repeıfusion injury In rat testis. Journal of Pediatric Urology DOI:http://dx,doi,orq/10,i016/i,ipurol. 2016.12.016 Sekerci CA, Tanidir Y, Şener TE, Şener G, Çevik O, Yarat A, Alev-Tuzuner B, Cetinel S, Kervancioglu E, Sahan A,
  • The Effects of Melatonin on Ethylene Glycol-induced Nephrolithiasis; Role on Osteopontin mRNA Gene Expression. Urology. 2017 Jan;99:287.e9-287.el5. doî:10.1016/j.urology.2016.09.032. PubMed PMID: 27717860. Şener TE, Şener G, Çevik O, Eker P, Cetinel S, Traxer O, Tanidir Y, Akbal C.
  • Nonalcoholic Fatty Liver Disease is Associated with Erectile Dysfunction; A Prospective Pilot Study. J Sex Med. 2016 Mar;13{3):383-8. doi; 10,1016/j.jsxm,2015.12.030. PubMed PMID: 26853046. Duman DG, Biçakci E, Çelikel ÇA, Akbal C.
  • Resistant pediatric priapism: A real challenge for the urologist. Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E562-4. doi: 10.5489/cuaj.2952. PubMed PMID: 26609335;PubMed Central PMC1D: PMC4641879. Sekerci CA, Akbal C, SenerTE, Sahan A, Sahin B, Baltacioglu F, Simsek F.
  • Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats. Clin Exp Pharmacol Physiol. 2014 Apr;41(4):309-16. doi: 10.1111/1440-1681.12216. PubMed PMID: 24552354. Tavukçu HH, Sener TE, Tinay I, Akbal C, Erşahin M, Çevik O, Cadirci S, Reiter R3, Şener G
  • Mesenchymal stem cell therapy in treatment of erectile dysfunction: autologous or allogeneic cell sources? Int 3 Urol. 2014 Dec;21(12):1280-5, doi: 10.1111/iju.12585. PubMed PMID: 25074479. Mangir N, Akbal C, Tarcan T, Simsek F, Turkeri L.
  • Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimusca Korean 3 Urol. 2014 Apr;55(4):281-7. doi:10.4111/kju.2014.55.4.281. PubMed PMID: 24741419; PubMed Central PMCID: PMC3988441. Tarcan T, Akbal C, Sekerci CA, Top T, Şimşek F.
  • Apocynin attenuates testicular ischemia-reperfusion injury in rats, J Pediatr Surg. 2015 Aug;50(8):1382-7. doi: 10,1016/j.jpedsurg.2014.11.033. PubMed PMID: 25783298, Şener TE, Yüksel M, Özyı!maz-Yay N, Ercan F, Akbat C, Şimşek F, Şener G.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 444 55 44 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP